Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, Kineta is raising $10,000,000.00 in new funding. Sources indicate as part of senior management President, Craig Philips played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Kineta

Kineta is a clinical stage biotechnology company committed to developing disruptive life science technologies in immuno-oncology, neuroscience and biodefense.

To learn more about Kineta, visit http://www.kinetabio.com/

Contact:
Craig Philips, President
206-378-0400
cphilips@kinetabio.com
https://www.linkedin.com/in/craigphilips/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved